Feedback

Monoclonal antibodies (mAbs) against cell surface markers, intracellular cytokine, nuclear protein or immunoglobulin used in this study.

  • Elaine M. S. Dorneles (494020)
  • Graciela K. Lima (443292)
  • Andréa Teixeira-Carvalho (1805704)
  • Márcio S. S. Araújo (789876)
  • Olindo A. Martins-Filho (294737)
  • Nammalwar Sriranganathan (28009)
  • Hamzeh Al Qublan (793414)
  • Marcos B. Heinemann (494027)
  • Andrey P. Lage (494028)
Open link
Publication date
September 2015
Icon DOI
10.1371/journal.pone.0136696.t001

Abstract

<p><sup>a</sup>mAb purchased from AbD Serotec (Raleigh, USA).</p><p><sup>b</sup>mAb purchased from VMRD (Pullman, USA).</p><p><sup>c</sup>mAb purchased from Life Technologies (Carlsbad, USA).</p><p><sup>d</sup>mAb purchased from eBioscience (San Diego, USA).</p><p><sup>e</sup>mAb purchased from R&D Systems (Minneapolis, USA).</p><p><sup>f</sup>mAb purchased from BD Pharmingen (San Diego, USA).</p><p><sup>g</sup>fluorescein isothiocyanate (FITC).</p><p><sup>h</sup>phycoerythrin (PE).</p><p><sup>i</sup>horseradish peroxidase.</p><p>Monoclonal antibodies (mAbs) against cell surface markers, intracellular cytokine, nuclear protein or immunoglobulin used in this study.</p

Extracted data

We use cookies to provide a better user experience.
Data Protection